Cytomegalovirus, Everolimus, Kidney transplant, Mycophenolate mofetil, Rejection
dx.doi.org/10.1097/01.TP.0000141094.34903.54, hdl.handle.net/1765/65839
Transplantation
Department of Internal Medicine

Vitko, S, Margreiter, R, Weimar, W, Dantal, J, Viljoen, H.G, Li, Y, … Cretin, N. (2004). Everolimus (certican) 12-month safety and efficacy versus mycophenolate mofetil in de Novo renal transplant recipients. Transplantation, 78(10), 1532–1540. doi:10.1097/01.TP.0000141094.34903.54